Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01058382 · ClinicalTrials.gov registry record
Progesterone Support of FET
A clinical trial of Frozen Embryo Pregnancy Rate, sponsored by Charles Coddington.
- Completed
- Registry status
- 57
- Enrollment target
- 1
- Study location
NCT01058382: Completed study of Frozen Embryo Pregnancy Rate, sponsored by Charles Coddington.
NCT01058382 is a study of Frozen Embryo Pregnancy Rate that has completed, run by Charles Coddington. The registered enrollment target is 57 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01058382, a study of Frozen Embryo Pregnancy Rate, has completed, sponsored by Charles Coddington.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
There have been two very common forms of progesterone administration that have been used during ovulation induction, in vitro fertilization (IVF) and embryo transfers. There are currently no randomized clinical trials to demonstrate which method of progesterone administration is more effective for frozen embryo transfer. We raise the question: Is there a difference between the two accepted methods of progesterone administration, intramuscular and vaginal suppositories, for frozen embryo transfer? Studies for fresh embryo transfer after in vitro fertilization, have demonstrated that there is not a difference between the two methods of progesterone administration. We will evaluate the question for frozen embryo transfer.
Conditions Studied
Interventions
- DRUG Progesterone Vaginal Suppositories
- DRUG Intramuscular Progesterone-in-Oil
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-10 |
What the finished NCT01058382 record still lists
NCT01058382 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 1 condition, with Frozen Embryo Pregnancy Rate appearing as the primary indexed condition, and to 2 interventions - of which Progesterone Vaginal Suppositories is the first listed.
NCT01058382 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01058382 about?
NCT01058382 is a clinical study titled "Progesterone Support of FET". There have been two very common forms of progesterone administration that have been used during ovulation induction, in vitro fertilization (IVF) and embryo transfers. There are currently no randomized clinical trials to demonstrate which method of progesterone administration is more effective for f...
What is the current status of trial NCT01058382?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2010-02. Estimated completion is 2012-10.
What conditions does trial NCT01058382 study?
This clinical trial studies the following conditions: Frozen Embryo Pregnancy Rate.
What interventions are being tested in trial NCT01058382?
The interventions under investigation include: Progesterone Vaginal Suppositories (DRUG), Intramuscular Progesterone-in-Oil (DRUG).
Who is sponsoring clinical trial NCT01058382?
This trial is sponsored by Charles Coddington, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01058382 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia